For the best experience, please use a modern browser. E.g. Chrome, Safari or Firefox.

PMWC 2021 Silicon Valley Luminary & Pioneer Awards TBA
See 2020’s below:

The PMWC Luminary Award recognizes recent contributions of preeminent figures who have accelerated personalized medicine into the clinic. The PMWC Pioneer Award is given to a venerable individual whose foresight and groundbreaking contributions to Precision Medicine propelled the movement in its early years, allowing it to gain momentum to evolve into the standard of care that it is becoming today.

Awardees

Luminary Award

Leader in rapid neonatal molecular diagnosis using whole genome sequencing

Date & Agenda

When:

TBA

Agenda:

TBA

Where:

Santa Clara Convention Center

Suggested dress:

TBA

RSVP and separate registration required. Send inquiries by 1/4/20 to [email protected] To see if space is available.

Venue

Santa Clara Convention Center
Exhibition Hall C & D
5001 Great America Pkwy
Santa Clara, CA 95054

Parking & Directions

PARKING

1,500 on-site parking spaces in a 3-story adjacent parking garage (directions) on the Santa Clara Convention Center campus shared with the Hyatt Regency and TechMart. Additional overflow parking may be available in surrounding lots based on availability as well as the City of Santa Clara Garage (directions) across the street.

DRIVING DIRECTIONS
FROM SAN JOSE INTERNATIONAL AIRPORT – 5.4 MILES

Take San Jose International Airport’s Guadalupe Pkwy. Exit. Turn left on Guadalupe Pkwy. Follow onto I-101 North. Follow I-101 North roughly three miles and exit at Great America Pkwy. Turn right onto Great America Pkwy. The Silicon Valley Convention Center is located at Great America Pkwy. and Tasman Ave. You can find the Convention Center Parking Garage by exiting at the Hyatt Regency’s 2nd driveway at Bunker Hill Rd.

FROM SAN FRANCISCO INTERNATIONAL AIRPORT – 31 MILES

Follow San Francisco International Airport’s exit signs to I-101 South towards San Jose. Take I-101 South roughly 30-40 minutes and exit at Great America Pkwy. Turn left at Great America Pkwy. The Convention Center is at Great America Pkwy. and Tasman Ave. You can find the Silicon Valley Convention Center Parking Garage by exiting Great America Pkwy. at the Hyatt Regency’s 2nd driveway at Bunker Hill Rd.

FROM OAKLAND INTERNATIONAL AIRPORT –33.1 MILES

Exit Oakland International Airport and take Hegenberger Rd. to I-880 South towards San Jose. Take I-880 roughly 30-40 minutes to Highway 237 towards Mountain View. Follow Highway 237 to Great America Pkwy. Exit. Turn left on Great America Pkwy. The Convention Center is at Great America Pkwy. and Tasman Ave. You can find the Convention Center Parking Garage by exiting off Great America Pkwy. at the Hyatt Regency’s 2nd driveway at Bunker Hill Rd.

MARY V. RELLING

2018 – Michigan

Pioneered and advocate for pharmacogenomic personalized medicine

SUSAN A. MURPHY

2018 – Michigan

Developing innovative data science methods to improve patient care through mobile health in chronic disease

ERIC TOPOL

2018 – Michigan

Pioneered genetics and genomics in cardiovascular medicine and led the era of wireless medicine

Past Pioneer Award Recipients

The PMWC Pioneer Award is given to a venerable individual whose foresight and groundbreaking contributions to Precision Medicine propelled the movement in its early years, allowing it to gain momentum to evolve into the standard of care that it is becoming today.

Award Recipients: Silicon Valley

BROOK BYERS

2020

Enabled precision medicine through the venture backing of companies that entered the field early and through his mentorship of their founders

GEORGE D. YANCOPOULOS

2019

Developed Foundational Technologies Designed to Invent Groundbreaking Therapies

RONALD LEVY

2018

Pioneered the concept of antibodies being used as personalized anticancer drugs

SIR JOHN BELL

2018

Leading Genetic and Genomic Research Initiatives that Enable Precision Medicine in the UK and Globally

ALAN ASHWORTH

2018

Co-discovered the BRCA2 gene mutation and made discoveries leading to PARP inhibition in breast and other cancers

STEVE QUAKE

2017

Steve Quake has pioneered innovative approaches to biological measurement

IRV WEISSMAN

2016

Pioneer in Regenerative Medicine & Cancer Stem Cells

RALPH SNYDERMAN

2016

Widely recognized as “Father of Personalized Medicine”

CRAIG VENTER

2015

1st Draft Human Gen., 1st Complete Diploid Human Gen., and 1st Synth. Bact. Cell

DENNIS LO

2015

Discovered That An Unborn Fetus Releases Fetal DNA Into Maternal Plasma

YUET WAIN KAN

2014

The first to establish that a single DNA mutation could lead to a human disease, and the first to diagnose a human disease by using DNA

Award Recipients: Michigan

MICHAEL BOEHNKE

2018- Michigan

Pioneered large-scale studies identifying genetic risk in diabetes and Bipolar Disorder

Award Recipients: Duke

KATHY GIUSTI

2017- Duke

Pioneer in Business Leadership to Advance Life-Saving Therapies and Institutional Collaboration

MARK LEVIN

2017- Duke

Advances Personalized Medicine Through His Business, Science and Policy Acumen

Award Recipients: Israel

MICHAEL HAYDEN

2014 – Israel

Developer, First Predictive Test for Huntington’s Disease

KIM POPOVITS

2013 – Israel

Launched both earliest genetically-targeted therapy and molecular diagnostic assay

Most Promising Company Award 

 

 

The PMWC Most Promising Company Competition has accompanied PMWC since 2009 with the goal to assist “rising star” startups in Diagnostics, Therapeutics, and Health Tech to increase their visibility, provide them with a platform to present to a group of leading investors, as well as to potential clients and partners so they can succeed on their path forward.

abres

ABREOS BIOSCIENCES

Abreos Biosciences is a precision medicine company in San Diego, CA developing laboratory-based and near-patient tests for precision dosing of biologic drugs. Abreos has cultivated a diverse portfolio of Veritope™ tests that allow for direct monitoring of blood concentrations of monoclonal antibody drugs (novel or biosimilar). Website: abreos.com

Most-promising (1)
immusoft

IMMUSOFT

Immusoft’s mission is re-program patient cells into miniature drug factories that engraft and survive for decades in the body. Website: immusoft.com

pmwc2018SVaward_GENERAL

TWO PORE GUYS

Two Pore Guys created a solid-state nanopore-based diagnostic testing platform that can detect nucleic acids, proteins and other analytes with comparable performance of lab equipment, in a glucometer-style system. Website: twoporeguys.com

PMWC-2017-Company-Competition-Award

GRITSTONE ONCOLOGY

Every patient’s tumor is molecularly unique – Gritstone Oncology deploys a proprietary tumor antigen prediction model based upon patient tumor sequencing/mass spectrometry to deliver antigens as personalized therapeutic vaccine alongside checkpoint inhibitors. Website: gritstoneoncology.com

PMWC-2017-Company-Competition-Award

HEALTHMYNE

HealthMyne is an imaging informatics company dedicated to transforming patient care by enabling image data mining within the clinical workflow. Built on an FDA-cleared diagnostic platform, HealthMyne tools will increase radiologist efficiency by automating both data capture and structured reports. Website: healthmyne.com

PMWC-2016-Silicon-Valley

INSILICO MEDICINE

Insilico Medicine, Inc. is a bioinformatics company located at the Emerging Technology Centers at the Johns Hopkins University Eastern campus in Baltimore. It utilizes advances in genomics, big data analysis and deep learning for in silico drug discovery and drug repurposing for aging and age-related diseases. Website: insilicomedicine.com

PMWC-2015-Silicon-Valley

ACCEL DIAGNOSTICS

AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests at any time and any place. The patented pScreen™ platform technology employs a single-use blood test the size of a credit card in tandem with a smartphone application to quickly detect disease-specific biomarker levels. Website: acceldx.com

PMWC-2015-Silicon-Valley

T2 BIOSYSTEMS

T2 Biosystems is an in vitro diagnostics company that has developed an innovative and proprietary technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. Their new class of clinical diagnostics powered by T2MR is the world’s first direct detection technology that delivers superior sensitivity at unmatched speed to guide more effective clinical decision-making. IPO, Aug. 2014. Website: t2biosystems.com

PMWC-2014-Silicon-Valley

ELMINDA

ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks. Website: elminda.com

PMWC-2013-Israel

HORIZON DISCOVERY

Horizon Discovery Limited has developed a translational genomics platform and drug discovery toolbox that enables the development of new therapies targeted at the genetic features that drive an individual’s cancer. IPO, March 2014. Website: horizondiscovery.com

PMWC-2013-Silicon-Valley

QUANTALIFE

QuantaLife provides advanced genetic analysis systems for research. QuantaLife has commercialized the Droplet Digital™ (ddPCR) system, the most accurate genetic analysis platform available today. The system is the first cost-effective, high-resolution platform available for the validation of next-generation sequencing discoveries. With the ddPCR system, researchers can explore complex genetic landscapes in high-definition, discover new disease associations, and define a new category of improved molecular diagnostic tests. Acquired by Bio-Rad, October 2011. Website: bio-rad.com

PMWC-2010-Silicon-Valley

APPLIED IMMUNE TECHNOLOGIES

Applied Immune Technologies’ (AIT) core technology platforms encompass the identification and validation of novel MHC-based targets, as well as development of therapeutic Human Recombinant T-Cell Receptor-Like (TCRL) antibodies with the unique ability to bind with these intracellular peptide/MHC complexes with the specificity of cytotoxic T-cell killer cells. Acquired by Adicet Bio, January 2016.Website: tcrl.co.il

PMWC-2010-Israel-1

APPLIED IMMUNE TECHNOLOGIES

Boston Heart Diagnostics is a heart health management company providing integrated diagnostic and patient management solutions that are advancing cardiovascular disease risk assessment, monitoring and treatment. The Company’s goal is to predict, prevent, manage and reverse cardiovascular disease by improving patient assessment and management. Acquired by Eurofins Scientific, December 2014. Website: bostonheartdiagnostics.com

PMWC-2009-Silicon-Valley

PMWC – Leading & Original Conference for Precision Medicine
CO-HOSTED BY:

1280px-University_of_California_San_Francisco_logo.svg-1
logo-umichcolor
1280px-Duke_University_logo.svg-1
University_of_Pittsburgh_Logo_CMYK_Primary_3-Color
Stanford_HealthCare_Med_RGB-1

Testimonials